Replies to post #107211 on Anavex Life Sciences Corp (AVXL)

[kld2]

Agree Pineapple.

All I'm saying is that Missling emphasized ad nauseum the PK/PD analysis at last conference, months ago. And now we have another conference and no PK/PD analysis. I just might add: Ph2/3 trial has been in planning for many months now, per corporate presentations. What's the hold-up? The way things are going, it could be 2019 before we see data (and before anyone attacks me, just remember: it took them 8 months to enroll 32 pts; now we are talking about 300, and enrollment hasn't even begun. Complete enrollment surely will be 1H 2018, and then the trial, six months or longer; and the data, etc. 18 more months, at least.